Immune Response to Seasonal Influenza Vaccine in HIV Infected Individuals
A Study to Examine Immunological Response in HIV-Infected Patients Receiving the Seasonal Influenza Vaccine
Sponsor: George Washington University
This observational or N/A phase trial investigates Human Immunodeficiency Virus I Infection and Influenza, Human and is currently completed. George Washington University leads this study, which shows 8 recorded versions since 2009 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.
Status Flow
Change History
8 versions recorded-
Sep 2025 — Present [monthly]
Completed
-
Sep 2024 — Sep 2025 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jun 2023 — Jul 2024 [monthly]
Completed
-
Jan 2021 — Jun 2023 [monthly]
Completed
▶ Show 3 earlier versions
-
Jun 2018 — Jan 2021 [monthly]
Completed
-
Apr 2018 — Jun 2018 [monthly]
Completed
Phase: NA → None
-
Jan 2017 — Apr 2018 [monthly]
Completed NA
First recorded
Sep 2009
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- George Washington University
For direct contact, visit the study record on ClinicalTrials.gov .